Charlotte Proudhon's guest appearances

Charlotte Proudhon

Epigenetics Podcast

OwlTail

In this episode of the Epigenetics Podcast, we caught up with Charlotte Proudhon from the Institut Curie to talk about her work on circulating tumor DNA and circulating Epi-mutations as biomarkers in cancer. Charlotte Proudhon started out her research career by investigating circulating tumor DNA (ctDNA). This kind of DNA is shed into the bloodstream by apoptotic tumor cells and can be analyzed after collection by a simple blood draw, which makes it a very useful biomarker for cancer. Using this approach cancers can be identified by their unique mutational fingerprint. However, soon the limitations of this approach became apparent and the fact that this ctDNA is actually shed into the bloodstream as nucleosomal particles was utilized by the Proudhon team and now the methylation fingerprint of the LINE-1 repeats is used as a biomarker for cancer diagnosis and monitoring of the success of a cancer treatment.   References  Decraene, C., Silveira, A. B., Bidard, F. C., Vallée, A., Michel, M., Melaabi, S., Vincent-Salomon, A., Saliou, A., Houy, A., Milder, M., Lantz, O., Ychou, M., Denis, M. G., Pierga, J. Y., Stern, M. H., &amp; Proudhon, C. (2018). Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clinical chemistry, 64(2), 317–328. https://doi.org/10.1373/clinchem.2017.272518   Bortolini Silveira, A., Bidard, F. C., Tanguy, M. L., Girard, E., Trédan, O., Dubot, C., Jacot, W., Goncalves, A., Debled, M., Levy, C., Ferrero, J. M., Jouannaud, C., Rios, M., Mouret-Reynier, M. A., Dalenc, F., Hego, C., Rampanou, A., Albaud, B., Baulande, S., Berger, F., … Pierga, J. Y. (2021). Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. NPJ breast cancer, 7(1), 115. https://doi.org/10.1038/s41523-021-00319-4     Related Episodes  Epigenome-based Precision Medicine (Eleni Tomazou)   Epigenetics and Epitranscriptomics in Cancer (Manel Esteller)   DNA Methylation and Mammalian Development (Déborah Bourc'his)     Contact  Epigenetics Podcast on Twitter   Epigenetics Podcast on Instagram   Epigenetics Podcast on Mastodon   Active Motif on Twitter   Active Motif on LinkedIn   Email: podcast@activemotif.com 

In this episode of the Epigenetics Podcast, we caught up with Charlotte Proudhon from the Institut Curie to talk about her work on circulating tumor DNA and circulating Epi-mutations as biomarkers in cancer. Charlotte Proudhon started out her research career by investigating circulating tumor DNA (ctDNA). This kind of DNA is shed into the bloodstream by apoptotic tumor cells and can be analyzed after collection by a simple blood draw, which makes it a very useful biomarker for cancer. Using this approach cancers can be identified by their unique mutational fingerprint. However, soon the limitations of this approach became apparent and the fact that this ctDNA is actually shed into the bloodstream as nucleosomal particles was utilized by the Proudhon team and now the methylation fingerprint of the LINE-1 repeats is used as a biomarker for cancer diagnosis and monitoring of the success of a cancer treatment. References <ul><li> Decraene, C., Silveira, A. B., Bidard, F. C., Vallée, A., Michel, M., Melaabi, S., Vincent-Salomon, A., Saliou, A., Houy, A., Milder, M., Lantz, O., Ychou, M., Denis, M. G., Pierga, J. Y., Stern, M. H., &amp; Proudhon, C. (2018). Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clinical chemistry, 64(2), 317–328. <a href="https://doi.org/10.1373/clinchem.2017.272518" rel="nofollow" target="_blank">https://doi.org/10.1373/clinchem.2017.272518</a> </li> <li> Bortolini Silveira, A., Bidard, F. C., Tanguy, M. L., Girard, E., Trédan, O., Dubot, C., Jacot, W., Goncalves, A., Debled, M., Levy, C., Ferrero, J. M., Jouannaud, C., Rios, M., Mouret-Reynier, M. A., Dalenc, F., Hego, C., Rampanou, A., Albaud, B., Baulande, S., Berger, F., … Pierga, J. Y. (2021). Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. NPJ breast cancer, 7(1), 115. <a href="https://doi.org/10.1038/s41523-021-00319-4" rel="nofollow" target="_blank">https://doi.org/10.1038/s41523-021-00319-4</a> </li> </ul> Related Episodes <ul><li> <a href="https://www.activemotif.com/podcasts#eleni-tomazou" rel="nofollow" target="_blank">Epigenome-based Precision Medicine (Eleni Tomazou)</a> </li> <li> <a href="https://www.activemotif.com/podcasts#manel-esteller" rel="nofollow" target="_blank">Epigenetics and Epitranscriptomics in Cancer (Manel Esteller)</a> </li> <li> <a href="https://www.activemotif.com/podcasts#deborah-bourchis" rel="nofollow" target="_blank">DNA Methylation and Mammalian Development (Déborah Bourc'his)</a> </li> </ul> Contact <ul><li> <a href="https://twitter.com/epigenetics_pod" rel="nofollow" target="_blank">Epigenetics Podcast on Twitter</a> </li> <li> <a href="https://www.instagram.com/epigenetics_pod/" rel="nofollow" target="_blank">Epigenetics Podcast on Instagram</a> </li> <li> <a href="https://podcasts.social/@epigenetics_pod" rel="nofollow" target="_blank">Epigenetics Podcast on Mastodon</a> </li> <li> <a href="https://twitter.com/activemotif" rel="nofollow" target="_blank">Active Motif on Twitter</a> </li> <li> <a href="https://www.linkedin.com/company-beta/35651/" rel="nofollow" target="_blank">Active Motif on LinkedIn</a> </li> <li> Email: <a href="mailto:podcast@activemotif.com">podcast@activemotif.com</a> </li></ul>